SignalTrace

Tag: SGLT2i

3 items with this tag.

  • May 10, 2026

    SGLT2 Inhibitors

    • comparator
    • SGLT2i
    • CKD
    • cardiovascular
    • kidney
    • outcomes_trial
    • CREDENCE
    • DAPA-CKD
    • EMPA-KIDNEY
    • EMPA-REG
  • May 10, 2026

    ADA/EASD 2022 Consensus Report — Management of Hyperglycaemia in Type 2 Diabetes

    • guideline
    • ADA
    • EASD
    • consensus
    • diabetes_guideline
    • type_2_diabetes
    • tirzepatide
    • GLP-1
    • SGLT2i
  • May 10, 2026

    KDIGO 2022 Clinical Practice Guideline — Diabetes Management in Chronic Kidney Disease

    • guideline
    • KDIGO
    • CKD
    • kidney
    • diabetes_guideline
    • type_2_diabetes
    • SGLT2i
    • GLP-1
    • tirzepatide

Research by John Montgomery · SignalTrace

This vault is one of SignalTrace's primary-source research investigations — every claim traced to the document it came from. SignalTrace builds the same queryable, fully-cited knowledge graphs on commission.

SignalTrace homeAbout the methodCommission a vault

▲ SignalTrace
𝕏inEdenFinTech ↗
© 2026 SignalTrace · Skin in the game.
MethodCasesDepthContact